|
Workshop
Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
Speakers:
Organizers:
Date:
2019-03-11- 3/15/2019
Time:
8:30-17:00 Pacific Time
Registration fee:
(USD): One-week full course: $1865; Mon AM: Drug Development Process: $250; Mon PM: Science of Clinical Trials Design: $250; Tue AM: GCP & ICH Investigator & Clinical Research Site: $250; Tue PM: Study Site Perspective & Applied Statistics in Clinical Trials: $250; Wed AM: Monitoring Clinical Trials: $250; Wed PM: Medical Devices: $250; Thur AM: Clinical Data Management: $250; Thur PM: Clinical QA/Compliance Audits and the FDA: $250; Fri AM: Good Manufacturing Practices and regulatory trends: $250; Fri PM: Global Clinical Trials Perspective; Business of Clinical Research: $250
Location:
Santa Clara, CA (3175 Bowers Avenue)
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2019-03-06
(it will close sooner if the seating cap is reached)
About the Topic
Clinical Trials Essentials: An Intensive One-Week Course
Well-planned and well-executed clinical trials are the cornerstones of effective drug and medical device development. Offered in an accelerated format and taught by leaders in the biopharmaceutical industry, this course provides a unique opportunity for professionals from all disciplines to learn about the many facets of clinical trials--the complex process that ensures the safety and effectiveness of medical products.
Participants leave the program with an appreciation of the drug and device development process; as well as good clinical practice (GCP) and other regulations (ICH and FDA) that guide the conduct of trials and protect human volunteers. Also covered are clinical trial phases and design strategies; the importance of informed consent and the role of the IRB; investigator selection and responsibilities; study site management and trial monitoring; statistical data analysis; and regulatory responsibilities and the role of the FDA.
This course benefits anyone working in the biopharmaceutical and medical device industries and the biomedical community who is interfacing with or conducting clinical research, including new clinical research associates and study coordinators, medical directors, physicians, nurses, pharmacists, and other health professionals, biomedical scientists, statisticians and database administrators, and business professionals.
A team of clinical research experts, including many instructors from the UCSC Extension Clinical Trials Design and Management Certificate Program, address the following:
Topics include:
- Drug and Medical Device Development Processes
- Clinical Trial Design
- Applied Statistics in Clinical Trials for the Non-Statistician
- Regulation of Clinical Research
- Roles and Responsibilities of Key Clinical Research Players
- Monitoring Clinical Trials
- Clinical Data Management
- Clinical QA, Auditing and Compliance
- GMP and the Transition to Full Scale Manufacturing
- Business of Clinical Research
- Globalization of Clinical Research
Agenda:
Monday March 11, 2019 – 8:30 am—12:30 pm
Drug Development Process 4 hours – Edward Rozhon
- Major players in drug development
- Assay development and discovery of new medical entities
- Non clinical and clinical development of new drugs
- History and regulatory oversight of FDA
- Structure of Phase I, II, & III clinical trials
- FDA review of New Drug Application
Monday March 11, 2019 – 1:30 pm—5:30 pm Science of Clinical Trials Design 4 hours – Romi Behbehanian
- Phases of drug development
- Objectives of clinical studies
- Basic clinical trials designs
- Underlying science for clinical trials designs
Tuesday March 12, 2019 – 8:30 am—12:30 pm GCP & ICH Investigator & Clinical Research Site 4 hours – Narinder Singh
- Historical and legislative roads to Good Clinical Practices (GCP)
- Principles of GCP and the research-care conflict
- Role of various stakeholders in Clinical Trials
- Elements of informed consent
Tuesday March 12, 2019 – 1:30—3:00 pm
Study Site Perspective 1.5 hours – Gerri O’Riordan
- Translational research in an academic center: fundamental strengths and weaknesses
- Research Process and Operations management as the success of a trial
- Essential conversations between academia, biomedical and pharmaceutical companies, venture capitalists and consultants
- Data Integrity and well-supported metrics (Case Studies)
Tuesday March 12, 2019 – 3:15 pm—5:30 pm
Applied Statistics in Clinical Trials 2.25 hours – Pete Shabe
- The role statistics plays in clinical research
- Basic data summarization techniques
- Estimation and Hypothesis Testing Introduction
- Estimation and Confidence Intervals
- Statistical Hypothesis Testing
Wednesday March 13, 2019 – 8:30 am—12:30 pm
Monitoring Clinical Trials 4 hours – Savita Sinha
- Review the basic regulatory requirements of monitoring a clinical research study
- Describe the tasks that should be performed before, during, and after a monitoring visit
- Learn how to track all key parameters involved in monitoring a site
- Know how to complete visit reports and follow-up on action items after each site visit
Wednesday March 13, 2019 – 1:30 pm—5:30 pm
Medical Devices, An Overview 4 hours – Clarisa Tate
- What is a medical device, a general overview of regulations
- Medical devices regulatory pathways: 510(k), PMA, and HDE
- Medical device clinical trials: Focus on Investigational Device Exemptions
- Post-market surveillance: Focus on 522, complaints, and recalls
- Globalization and changing regulatory environment
Thursday March 14, 2019 – 8:30 am—12:30 pm
Clinical Data Management 4 hours – Amanda Whalen
- Key data management activities for study startup, conduct, and closeout
- Regulations applicable to data management activities
- Clinical data management systems and electronic data capture (EDC)
- Working with contract research organizations (CROs) for data management
Thursday March 14, 2019 – 1:30 pm—5:30 pm
Clinical QA/Compliance Audits and the FDA 4 hours – Frances Ann McKenney
- Qualifications needed for GXP auditors and FDA Inspectors
- Objectives of sponsor audits and regulatory inspections
- Similarities and differences between sponsor audits and regulatory inspections
- General approach to hosting an audit or inspection
- Types of findings that cause concern for auditors or inspectors
Friday March 15, 2019 – 8:30 am—12:30 pm
Good Manufacturing Practices and regulatory trends 4 hours – Narinder Singh
- Good Manufacturing Practices (GMP) for drugs
- GMP for biologics and related products, including Good Tissue Practices
- Considerations for Quality Systems
Friday March 15, 2019 – 1:30 pm—3:00 pm
Global Clinical Trials Perspective 1.5 hour – Narinder Singh
- Trends in global clinical trials
- Role of FDA and local regulatory culture
Friday March 15, 2019 – 3:15 pm—5:30 pm
Business of Clinical Research 2 hours – Maria Filippou-Frye
- The Market Players – Pharma, Biotech, Contract Research Organizations (CROs)
- Cost of Doing Business – Cost of conducting clinical research
- Outsourcing and CROs – It costs money to make money
- Innovative Ways to Reduce Cost – Business Strategies and Process Innovations
2024-04-26, [In-Person] Oncology Clinical Dose Optimization in Light of FDA Project Optimus
|
2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies
|
2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals
|
2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
2024-05-30, [Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)
|
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics
|
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
|
2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
|
2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices
|
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Lena Biosciences
Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
|
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Submit a Text Ad
|